Oak Grove Capital LLC Gilead Sciences, Inc. Transaction History

Oak Grove Capital LLC

$643 Million
Q3 2024

A detailed history of Oak Grove Capital LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Oak Grove Capital LLC holds 12,000 shares of GILD stock, worth $1.11 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

12,000

Previous 10,600 13.21%

Holding current value

$1.11 Million

Previous $727,000 38.24%

% of portfolio

0.16%

Previous 0.12%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $93,226 - $117,586	1,400 Added 13.21%	12,000 $1.01 Million
Q2 2024 Aug 05, 2024	BUY	$63.15 - $72.88 $669,390 - $772,528	10,600 New	10,600 $727,000
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $369,408 - $416,064	-6,400 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $257,744 - $322,981	-4,450 Reduced 41.01%	6,400 $380,000
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $246,543 - $279,832	-3,800 Reduced 25.94%	10,850 $788,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $1.73 Million - $1.86 Million	-25,531 Reduced 63.54%	14,650 $1.02 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $2.36 Million - $2.58 Million	-37,171 Reduced 48.05%	40,181 $2.77 Million
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $96,000 - $109,535	-1,600 Reduced 2.03%	77,352 $5 Million
Q4 2020 Feb 17, 2021	BUY	$56.65 - $64.55 $713,903 - $813,459	12,602 Added 18.99%	78,952 $4.6 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $1.87 Million - $2.36 Million	30,171 Added 83.39%	66,350 $4.19 Million
Q2 2020 Aug 24, 2020	SELL	$72.34 - $84.0 $4.33 Million - $5.03 Million	-59,850 Reduced 62.32%	36,179 $2.78 Million
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $6.42 Million - $8.22 Million	-102,496 Reduced 51.63%	96,029 $7.18 Million
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $206,427 - $227,063	-3,350 Reduced 1.66%	198,525 $12.9 Million
Q3 2019 Oct 30, 2019	BUY	$62.51 - $69.0 $6.01 Million - $6.63 Million	96,100 Added 90.85%	201,875 $12.8 Million
Q2 2019 Aug 09, 2019	BUY	$61.87 - $69.38 $3.27 Million - $3.66 Million	52,800 Added 99.67%	105,775 $7.15 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $1.4 Million - $1.57 Million	22,350 Added 72.98%	52,975 $3.44 Million
Q4 2018 Feb 15, 2019	BUY	$60.54 - $79.0 $805,182 - $1.05 Million	13,300 Added 76.77%	30,625 $1.92 Million
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $35,640 - $39,460	-500 Reduced 2.81%	17,325 $1.34 Million
Q2 2018 Nov 09, 2018	BUY	$64.88 - $75.68 $155,712 - $181,632	2,400 Added 15.56%	17,825 $1.26 Million
Q1 2018 Nov 09, 2018	SELL	$72.84 - $88.8 $950,562 - $1.16 Million	-13,050 Reduced 45.83%	15,425 $1.16 Million
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $2.03 Million - $2.38 Million	28,475	28,475 $2.04 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Grove Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Grove Capital LLC with notifications on news.

Account

Oak Grove Capital LLC Gilead Sciences, Inc. Transaction History